Inulin enzymatically synthesized from sucrose is a dietary component that completely escapes glucide digestion. Supplementing inulin to a high-fat and high-sucrose diet (HF) ameliorated hypertriglycemia and hepatic steatosis in 8-week-fed rats by suppressing elevated levels of serum triacylglycerols, fatty acids, and glucose, and the accumulation of hepatic triacylglycerols and fatty acids. Inulin intake prevented phenobarbital (PB)-and dexamethasone-induced liver injuries in the HF group. No significant alteration in the baseline expression of CYP2B, CYP2C11, CYP3A, and NADPH-cytochrome P450 (P450) reductase mRNAs and proteins was found. In contrast, baseline and PB-treated expressions of CYP2E1 mRNA were reduced in HF-fed rats. The induction of P450s in response to PB was affected by the nutritional status of the rats; mRNA levels of CYP2B1 and CYP3A1 after PB treatment, as assessed by quantitative real-time polymerase chain reaction analysis were reduced in the inulin-supplemented HF (HF؉I) group, compared with those in the HF group. Western blot analysis detected the corresponding changes of CYP2B and CYP3A proteins. These alterations were correlated with changes in hepatic thiobarbituric acid-reactive substances. Furthermore, no significant difference in the expression of nuclear receptors constitutive androstane receptor, pregnane X receptor, and retinoid X receptor ␣ and coactivator peroxisome proliferator-activated receptor-␥ coactivator 1␣ proteins was found in the hepatic nucleus between the HF and HF؉I groups, but the expression of hepatocyte nuclear factor ␣ (HNF4␣) protein was significantly reduced in the HF؉I group. Taken together, these results indicate that inulin intake ameliorates PB-induced liver injury, associated with a decline in lipid accumulation and PB-induced expression of CYP2B and CYP3A, which may be related by a reduction in the nuclear expression of HNF4␣.
The liver plays a central role in metabolizing therapeutic drugs and environmental contaminants. The activities of drug-metabolizing enzymes in our body are affected by the genotypes of the translating gene and also by nongenetic factors including environmental factors. Nutritional status such as starvation, fasting, and high-lipid diet, and pathophysiological alterations such as diabetes have been reported to modulate liver microsomal cytochrome P450 (P450) composition, leading to altered hepatic metabolism of drugs, carcinogens, steroid hormones, and fatty acids. Uncontrolled diabetes enhances hepatic CYP2E1, CYP2B, CYP3A, and CYP4A expression (Woodcroft and Novak, 1999 ). An increase in the hepatic production and accumulation of triacylglycerols is frequently associated with metabolic syndromes such as hypertriglyceridemia, obesity, and insulin resistance. The accumulation of triacylglycerols, defined as hepatic steatosis, is proposed to be the setting for more severe liver diseases such as nonalcoholic steatohepatitis, possessing histologic signs of fibrosis and necroinflammation through to cirrhosis, terminal liver failure, and hepatocellular carcinoma (Bugianesi et al., 2002) . CYP2E1, a microsomal oxidase involved with fatty acid -oxidation as well as CYP4A, is up-regulated in nutritional statuses such as starvation, fasting, obesity, and hyperlipidemia (Hong et al., 1987; Johansson et al., 1988; Weltman et al., 1996; Leclercq et al., 2000) . The elevated expression of CYP2E1 has been largely attributed to the pathogenesis of liver disease in patients with nonalcoholic steatohepatitis (Weltman et al., 1996 (Weltman et al., , 1998 Leclercq et al., 2000; Emery et al., 2003; Chalasani et al., 2003) .
Biochemical processes that generate oxidative stress can initiate hepatocellular injury, and CYP2B, CYP2C, and CYP3A, as well as CYP2E1 and CYP4A, are microsomal sources producing prooxidants in liver cells, which create oxidative stress under uncoupling with antioxidants. Here we found that the intake of a high-fat and highsucrose diet (HF) for a long period (8 weeks) produced marked accumulation of hepatic and serum triacylglycerols in rats, leading to hypertriglycemia and hepatic steatosis but not hepatic necroinflammatory lesions. Also, there was no significant influence in the baseline levels of hepatic CYP2B, CYP2C, and CYP3A proteins, but levels of CYP2E1 and CYP4A proteins were reduced. In contrast, the administration of phenobarbital (PB) to HF-fed rats more promptly caused liver injury, leading to cell necrosis and inflammation, compared with the standard diet (SD)-fed rats and was associated with changes in PB-inducible P450 expression or via the constitutive androstane receptor (CAR)-mediated pathway associated with hepatic lipid accumulation.
Some dietary components that completely escape glucide digestion, such as resistant starch and oligofructose, have been demonstrated to exert systemic effects by modifying lipid metabolism (Younes et al., 1995; Daubioul et al., 2000) . In contrast to starch, inulin is fermentable dietary fiber, resistant to hydrolysis by pancreatic amylase and saccharidases in the upper gastrointestinal tract. Previous studies by our laboratory have demonstrated that inulin was produced enzymatically from sucrose, and that supplementing inulin to the HF diet for 12 weeks reduced elevated body weight and serum and hepatic levels of triacylglycerols in rats (Wada et al., 2005) . Interestingly, this study has demonstrated that PB-induced liver failure was suppressed in rats fed an inulin-supplemented HF diet. It is important to investigate whether the reduction in elevated levels of blood glucose and serum and hepatic lipids by supplementing inulin to the HF diet was associated with the down-regulation of P450 induction by PB, consequently leading to the suppression of liver injury. Hence, in this study, we characterized PB-induced P450 mRNA and protein profiles in connection with profiles of blood glucose and serum and hepatic lipids. Treatment of inulin-supplemented HF diet-fed rats with PB resulted in lower levels of CYP2B mRNA and protein than with only the SD or HF diet. PB induces CYP2B, CYP2C, and CYP3A via the activation of nuclear receptors, CAR and pregnane X receptor (PXR), which regulate the transactivation of those genes. Previous studies have demonstrated that hepatocyte nuclear receptor-4␣ (HNF4␣) is an important regulator of coordinate nuclear receptor (such as CAR and PXR)-mediated response to xenobiotics (Triona et al., 2003) , and that peroxisome proliferator-activated receptor-␥ coactivator-1␣ (PGC1␣) modulates the function of nuclear receptors such as CAR as a common coactivator (Puigserver and Spiegelman, 2003; Shiraki et al., 2003) . Little is known about the effects of nutritional status on baseline and xenobiotic-mediated expression of nuclear receptors (CAR, PXR, RXR␣ forming a heterodimer with CAR or PXR) and coactivator PGC1␣. Thus, we examined the effect of supplementing inulin to SD and HF diets on the hepatic expression of CAR, PXR, RXR␣, HNF4␣, and PGC1␣ mRNAs and nuclear expression of those proteins in rats.
Materials and Methods
Materials. Phenobarbital sodium (PB) was purchased from Wako Pure Chemicals (Osaka, Japan). Dexamethasone (DEX), pentoxyresorufin, and resorufin were obtained from Sigma-Aldrich (St. Louis, MO). Inulin, which consists of a linear polymer (average ratio of glucose/fructose, 1:17) having ␤(2-1) linkages of D-fructose with one terminal glucose, was synthesized enzymatically from sucrose by inulin-producing enzyme as described previously (Wada et al., 2005) . All other chemicals and solvents were of analytical grade and were obtained from commercial sources.
Experimental Animals. All studies followed protocols approved by the Institutional Animal Care and Life Committee, University of Shizuoka. Male Wistar rats were obtained from Japan SLC (Hamamatsu, Japan) at 4 weeks of age and were acclimatized for 1 week before the experiment. Animals were housed in stainless steel hanging cages with free access to food and water and maintained on a 12-h light/dark cycle. All animals were randomly assigned to SD, 5% inulin-supplemented standard diet (SDϩI), HF, or 5% inulin-supplemented high-fat and high-sucrose diet (HFϩI) for 4 and 8 weeks. The HF diet consisted of 19.7% casein, 1% soybean oil, 10% lard, 4% mineral mixture, 1% vitamin mixture, 0.15% choline chloride, 0.5% cholesterol, 0.25% sodium cholate, 3.4% cellulose, and 60% sucrose [23.9% lipid, 56.8% carbohydrate, and 19.3% protein (kJ) ], and the SD diet consisted of 23.8% crude protein, 5.1% crude fat, 3.2% crude fiber, 6.1% ash, 54% nitrogen-free extract, and 7.8% humidity [12.9% lipid, 60.4% carbohydrate, and 26.7% protein (kJ) ]. Three times per week, all rats were weighed, and food intake in grams was monitored. At 9 or 13 weeks of age, the rats in each group were administered PB (80 mg/kg) or vehicle (0.9% sodium chloride) by intraperitoneal injection once daily for 4 days, and dexamethasone (50 mg/kg) or vehicle (0.1 M citric acid in 0.5% methylcellulose) once daily for 3 days between 8:00 AM and 9:00 AM.
Blood and Tissue Sampling. The experiments were run 4 h after the last administration of PB. Rats were anesthetized with diethyl ether; then, the abdominal cavity was rapidly opened, and blood was rapidly and simultaneously drawn from the abdominal vena cava into syringes. Plasma samples were separated from blood collected into heparinized tubes by centrifugation, and serum samples were separated from blood by centrifugation after standing for 30 min at room temperature. The resulting plasma/serum was stored at Ϫ30°C until analysis. Livers were rapidly excised and weighed. The liver median lobe was excised for the preparation of microsomes and nuclear extracts and RNA extraction, or was fixed in 4% paraformaldehyde in 0.12 M sodium phosphate (pH 7.3) for histological examination. Aliquots were snapfrozen and stored at Ϫ80°C until analysis. Sections were stained with hematoxylin-eosin (HE) or Oil Red O.
Preparation of Microsomes. Liver microsomes were prepared by differential centrifugation, first at 9,000g for 15 min, followed by 105,000g for 60 min at 4°C, and stored at Ϫ80°C. The microsomal protein concentration was determined with a bicinchoninic acid protein assay kit (Pierce Chemical, Rockford, IL) using bovine serum albumin as a standard.
Preparation of Nuclear Extracts. Livers (about 1 g) were homogenized in 5 volumes of 10 mM HEPES-NaOH buffer (pH 7.6) containing 25 mM KCl, 2 M sucrose, 10% glycerol, 0.15 M spermine, 0.5 mM spermidine, 1 mM EDTA, 1 mM dithiothreitol, 1 g of leupeptin per ml, 1 g of pepstatin per ml, 1 g of aprotinin per ml, 0.1 mM phenylmethylsulfonyl fluoride, and 1 mM Na 3 VO 4 with a Teflon-glass homogenizer with three strokes. The homogenate was carefully layered onto 5 ml of the same buffer in a centrifuge tube, and this was followed by centrifugation at 25,000 rpm and 4°C for 60 min with an SW28 rotor (Himac CP56GII; Hitachi Koki, Hitachinaka, Japan). The precipitate was homogenized in 1 ml of lysis buffer (10 mM HEPES-NaOH buffer [pH 7.6] containing 0.1 M KCl, 3 mM MgCl 2 , 10% glycerol, 0.1 mM EDTA, 1 mM dithiothreitol, 1 g of leupeptin per ml, 1 g of pepstatin per ml, 1 g of aprotinin per ml, 0.1 mM phenylmethylsulfonyl fluoride, and 1 mM Na 3 VO 4 ) with a Dounce homogenizer 10 times. Sodium chloride solution was added to the homogenate to bring the final concentration to 0.4 M, and the homogenate was incubated at 4°C for 30 min with gentle shaking. The supernatant of the centrifugation at 105,000g for 20 min was dialyzed against 1 L of dialysis buffer (20 mM HEPES-NaOH buffer, pH 7.6, containing 0.1 M NaCl, 20% glycerol, 0.2 mM EDTA, 1 mM dithiothreitol, 1 g of leupeptin per ml, 1 g of pepstatin per ml, 1 g of aprotinin per ml, 0.1 mM phenylmethylsulfonyl fluoride, and 1 mM Na 3 VO 4 ) at 4°C overnight and stored at Ϫ80°C. The protein concentration was determined by the Bradford assay (Bio-Rad protein assay kit; Bio-Rad Laboratories, Hercules, CA) using bovine serum albumin as a standard.
Immunoblot Analysis. Microsomal proteins or nuclear extracts (20 g) were resolved on a sodium dodecyl sulfate-12.5% polyacrylamide gel, elec-troblotted onto a polyvinylidene difluoride membrane (Millipore Corporation, Bedford MA). The immunoblots were incubated with the following primary antibodies: rat CYP2B1, rat CYP2C11, rat CYP2E1, rat CYP3A2, rat CYP4A1, and rat NADPH-P450 reductase (Daiichi Pure Chemicals Co., Tokyo, Japan), mouse CAR, mouse PXR, human RXR␣, human HNF4␣, human PGC1␣, and human histone H1 (Santa Cruz Biotechnology, Santa Cruz, CA). Antigen-antibody complexes were detected using the appropriate secondary antibody conjugated with horseradish peroxidase and visualized with an enhanced chemiluminescence system (GE Healthcare Bio-Sciences, Piscataway, NJ).
Determination of mRNA Levels. Total RNA was prepared from the liver using TRIzol reagent (Invitrogen, Carlsbad, CA). Samples were quantitated by spectrophotometry, and 1 g of total RNA was used to generate cDNA by reverse transcription using SuperScript II (Invitrogen) according to the manufacturer's protocol. cDNA synthesized from 50 ng of total RNA was subjected to quantitative real-time polymerase chain reaction, as described previously , with an ABI PRISM 7000 Sequence Detector instrument (Applied Biosystems, Foster City, CA) using Premix Ex Taq reagent (TaKaRa Bio Inc., Otsu, Japan) for the TaqMan probe method or SYBR Premix Ex Taq reagent (TaKaRa Bio Inc.) for intercalation reaction with SYBR Green I according to the manufacturer's specifications. The TaqMan probes and primers for rat CAR and PXR were as reported previously (Hartley et al., 2004) ; and rat CYP2E1 (assay identification number Rn00580624 m1), rat HNF4␣ (assay identification number Rn00573309 m1), and rat ␤-actin (assay identification number Rn00667869 m1) were assay-ondemand gene expression products (Applied Biosystems). The gene-specific probes were labeled by using reporter dye 5-carboxyfluorescein, and the ␤-actin internal control probe was labeled with a different reporter dye, 6-carboxyrhodamine, at the 5Ј end. The primers for rat CYP2B1, rat CYP2B2, rat CYP3A1, and rat CYP3A2 (Yoshinari et al., 2004) , rat CYP2C11 (Xu et al., 2001) , rat CYP4A1, rat CYP4A2, rat CYP4A3 (Marji et al., 2002) , rat RXR␣ , and rat PGC1␣ (Zhang et al., 2005) were as reported previously; the primers for rat NADPH-cytochrome P450 reductase were 5Ј-CATGTCCGCAGACCCTGAA-3Ј (forward primer) and 5Ј-CGTATGTG-GCCATGCAGAAG-3Ј (reverse primer), and the primers for rat ␤-actin were 5Ј-TCCTAGCACCATGAAGATC-3Ј (forward primer) and 5Ј-AAACG-CAGCTCAGTAACAG-3Ј (reverse primer). The thermal cycle conditions were as follows: hold for 10 s at 95°C, followed by two-step polymerase chain reaction for 40 cycles of 95°C for 5 s, followed by 60°C for 30 s. ␤-Actin was used to normalize gene expression in all samples. Fold-induction values were calculated by subtracting the mean difference of gene and ␤-actin cycle threshold Ct numbers for each treatment group from the mean difference of gene and ␤-actin Ct numbers for the vehicle group and raising the difference to the power of 2 (2 Ϫ⌬⌬Ct ). Biochemical Analyses. Plasma concentrations of glucose and fructose were determined by the hexokinase method using commercial reagents (R-Biopharm AG, Darmstadt, Germany). Serum glucose concentration was determined by the glucose oxidase method with a commercially available kit from Shino Test (Tokyo, Japan). Plasma/serum insulin was measured using a double-antibody radioimmunoassay kit specific for rat insulin (Eiken Chemical Co., Tokyo, Japan). Serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and ␥-glutamyltranspeptidase (␥-GTP) were measured using kits from Wako Pure Chemicals. Serum levels of triacylglycerol, total cholesterol, and nonesterified fatty acid were measured enzymatically with kits from Shino Test. Serum concentrations of ␤-hydroxybutyrate were measured using commercial reagents (Serotec Co., Sapporo, Japan). Frozen livers (about 0.5 g) were homogenized in 20 volumes (the SD and SDϩI groups) and 100 volumes (the HF and HFϩI groups) of 0.9% NaCl containing 0.1% Triton X-100, and the concentrations of triacylglycerol, total cholesterol, and nonesterified fatty acid were estimated with the above commercial kits. Frozen livers (about 0.5 g) were homogenized in 100 volumes of 0.9% NaCl, and thiobarbituric acid-reactive substances (TBARS) were measured in 20 l of liver homogenate using a commercial assay kit (ZeptoMetrix Co., Buffalo, NY). Liver tumor necrosis factor (TNF) ␣ and interleukin 6 were measured in 12.5 l of serum or liver homogenate using commercial enzyme-linked immunosorbent assay kits (GE Healthcare Bio-Sciences).
Resorufin Assay. The O-dealkylation of 7-pentoxyresorufin was measured fluorometrically by the production of resorufin using a Wallac 1420 ARVO plate reader (PerkinElmer Inc., Wellesley, MA) with excitation and emission wavelengths at 550 nm and 590 nm, respectively. The incubation mixtures contained Tris-HCl (100 mM, pH 7.4), MgCl 2 (3.3 mM), EDTA (1 mM), glucose 6-phosphate (3.3 mM), NADP (1.3 mM), glucose-6-phosphate dehydrogenase (0.4 U/ml), pentoxyresorufin (5 M), and microsomal protein from control rats and PB-treated rats (25 and 2.5 g/ml, respectively). NADPH was produced using the Gentest NADPH regenerating system (BD Biosciences, Woburn, MA). The mixtures were incubated for 10 min at 37°C. The formation rate of resorufin was determined by comparison to the fluorescence of known amounts of resorufin.
Statistics. Values are expressed as the mean Ϯ standard error. All data were analyzed using one-way analysis of variance. The difference between the means of the groups was tested for significance using Student's t test. The level of statistical significance was set at p Ͻ 0.05.
Results

Dietary Inulin Ameliorates the Development of Fatty Livers in
Rats Fed a High-Fat-and High-Sucrose-Supplemented Diet for 8 Weeks. We previously reported that supplementing inulin for 12 weeks reduced the elevation in body weight and serum and hepatic levels of triacylglycerols in rats fed high-fat (10% lard) and highsucrose (60%) diet (HF), whereas inulin intake for 12 weeks in rats fed the SD diet containing naturally existing starch as carbohydrate did not affect the body weight and serum and hepatic levels of lipids (Wada et al., 2005) . Consistent with these observations, supplementing inulin even for 8 weeks reduced the elevation of body weight, liver weight, serum levels of triacylglycerols, fatty acids and glucose, and hepatic levels of triacylglycerols in rats fed the HF diet, but did not significantly alter body weight, liver weight, and serum levels of lipids and glucose in rats fed the SD diet (Table 1) . At this time, there were no significant differences among the four diet groups in the food intake and starting body weight (data not shown). No significant change in serum and hepatic levels of total cholesterol was found by inulin intake (Table 1 ). In contrast, the hepatic levels of triacylglycerol (72.6 Ϯ 8.7 mg/g liver) in rats fed the HF diet for 8 weeks were significantly elevated compared with those in rats fed the HF diet for 4 weeks (43.8 Ϯ 5.0 mg/g liver), and supplementing inulin to the HF diet suppressed the accumulation of hepatic triacylglycerols (44.8 Ϯ 5.8 mg/g liver) in 8-week-fed rats. In addition, compared with hepatic free fatty acid levels in rats fed the SD diet for 8 weeks and in rats fed the HF diet for 4 weeks (18.5 Ϯ 0.6 Eq free fatty acid/g liver), intake of the HF diet for 8 weeks resulted in significantly higher accumulation of hepatic free fatty acid, and supplementing inulin to the HF diet reduced the accumulation of hepatic free fatty acids in 8-week-fed rats (Table 1 ). These observations indicate that inulin intake suppressed the further development of hepatic steatosis. In addition, when we measured serum levels of insulin and ␤-hydroxybutyrate in 8-weekfed rats, there was no significant change in either level in the four diet groups (data not shown). We interpret these data as indicating that feeding the HF diet for a long period (8 weeks) produced severe hepatic steatosis but did not induce diabetes.
Histological analysis of livers with HE and Oil Red O staining showed that steatosis was significantly improved after HF diet feeding for 8 weeks. As shown in Fig. 1, A and B, lipid droplets accumulated in the cytoplasm of hepatocytes in both periportal and pericentral areas in the HF group. In comparison, lipid droplet accumulation in hepatocytes was significantly reduced in the HFϩI group.
Dietary Inulin Ameliorates Drug-Induced Liver Injury in Rats with Fatty Liver. PB administration has been reported to induce oxidative changes in rat liver, detected as elevated hydroxyl radical levels (Kinoshita et al., 2002) . We compared drug-induced liver injury in rats fed the SD and HF diets. Treatment of 8-week-fed rats with PB at a dose of 80 mg/kg once daily for 4 days resulted in increased liver weights and liver-to-body weight ratios in the SD, SDϩI, HF, and HFϩI groups, and increased hepatic triacylglycerol levels in the HF and HFϩI groups (Table 1) . Staining of HF-fed rat liver with Oil Red O confirmed the lipid content of clear macrovacuoles (Fig. 1B) , but there were few areas in the SD-fed rat liver stained with Oil Red O (data not shown). In addition to the further development of hepatic steatosis, there were areas of mixed inflammatory cell infiltration and hepatocyte necrosis dissecting the liver parenchyma after PB treatment (Fig. 1, A and B) . Consistent with morphological changes, PB treatment of HF-fed rats resulted in significant increases in serum AST and ALT levels, but slight increases in serum ␥-GTP levels, compared with those in the SD group (Fig. 2) . At this time, the liver injury in the HF group was not accompanied by high levels of serum and hepatic TNF␣ and interleukin 6, inasmuch as there was no significant difference of the TNF␣ and interleukin 6 levels in the four diet groups (data not shown). Furthermore, treatment of rats with dexamethasone at a dose of 40 mg/kg once daily for 3 days (p.o.) resulted in significant increases in serum levels of AST and ALT in the SD, HF, and HFϩI groups (Fig. 2) . In contrast, inulin intake reduced the levels of serum AST and ALT in the HF group near to the levels in the SD group (Fig. 2) . Correspondingly, hepatocyte necrosis was significantly attenuated in rats fed an inulin-supplemented HF diet after PB treatment (Fig. 1) .
To examine whether the development of hepatic steatosis was associated with the setting of PB-induced liver injury, we compared serum AST and ALT levels after PB treatment in rats fed the SD and HF diets for 4 and 8 weeks. Figure 3 shows that treatment of 8-week-fed rats with PB at a dose of 80 mg/kg once daily for 4 days caused elevated levels of AST and ALT, but treatment of 4-week-fed rats with PB did not elevate the levels. These results suggest that hepatic steatosis further developed by feeding the HF diet for 8 weeks may be given to produce PB-and DEX-induced liver injury, and that inulin intake may ameliorate PB-and DEX-induced liver injury by reducing accumulated lipids such as triacylglycerols and free fatty acids in rat hepatocytes.
Next, to assess oxidative changes induced by PB administration in rat liver, we measured TBARS. As indicated by the accumulation of TBARS, the amount of total lipid peroxides was slightly higher in the livers of rats fed the HF diet and administered PB than in the livers of rats fed the inulin-supplemented HF diet and administered PB (Fig. 4) . In contrast, there was no significant change between hepatic TBARS levels in rats fed SD and SDϩI diets (Fig. 4) . These observations indicate that lowered lipid accumulation by inulin intake may be associated with the reduction of lipid peroxides produced by PB administration in the HF diet group (Fig. 4) .
Hepatic Expression and Induction by PB of Enzyme Activities, mRNAs, and Proteins of P450s in Rats Fed the Four Diets. Since PB particularly induces CYP2B1/2B2 expression in rat liver, we first compared the enzyme activity of pentoxyresorufin O-dealkylation (PROD) activities in the four diet groups. As shown in Table 1 , the HF and HFϩI diets did not influence baseline or induced levels of microsomal protein. Although the HF diet did not influence the baseline and induced levels of PROD activity, lower PROD activity in the HFϩI group than in the SD group after PB treatment was detected (Table 1) .
To assess the effects of the SD, SDϩI, HF, and HFϩI diets on the hepatic expression of baseline and PB-treated P450 mRNAs, we measured hepatic mRNA levels in rats fed the four diets with and without PB treatment. Unexpectedly, fatty liver produced by feeding the HF diet down-regulated CYP2E1 mRNA expression to 69 Ϯ 2% of the control (Table 2 ). The reduced levels were continued even after PB treatment for 4 days. Supplementing inulin to the HF diet did not reverse the mRNA levels of CYP2E1 (Table 2 ). In addition, there was no significant increase in the levels of CYP4A1, CYP4A2, and CYP4A3 in the vehicle-and PB-treated HF and HFϩI groups. As shown in Table 2 , there was no significant change in baseline mRNA levels of CYP2B1/2B2, CYP2C11, CYP3A1/3A2, and NADPH-P450 reductase in the four diet groups. As expected, PB treatment markedly increased CYP2B1/2B2 mRNA levels in the four diet groups. PB-induced mRNA levels of CYP2B1 and CYP2B2 in the HFϩI group were significantly lower than in the SD group. Whereas there was no significant change in PB-induced mRNA levels of CYP2B1 and CYP2B2 between the SD and SDϩI groups, PBinduced expression of CYP2B1 mRNA in the HFϩI group significantly declined compared with that in the HF group. PB-induced mRNA levels of CYP3A1 in the HF group were decreased compared with those in the SD group, and mRNA levels in the HFϩI group were further decreased compared with those in the HF group. There was no significant difference in PB-induced mRNA levels of CYP3A2 in the four diet groups. The mRNA levels of NADPH-P450 reductase in the SD and SDϩI groups were increased after PB treatment. Whereas there was no significant difference in PB-treated mRNA levels of NADPH-P450 reductase in the SD and HF groups, the levels in the HFϩI group were lower than those in the SD group.
Next, we compared protein levels of P450s in the four diet groups. The baseline and treated protein levels of CYP4A and PB-treated levels of CYP2E1 were decreased in the HF and HFϩI groups (Fig.  5) . There was no significant change in the baseline protein levels of CYP2B, CYP2C, CYP3A, and NADPH-P450 reductase except for decreased levels of CYP2B protein in the HFϩI group. The protein levels of CYP2B in the HF and HFϩI groups after PB treatment were decreased to 76 Ϯ 2% and 56 Ϯ 1%, respectively, of those in the SD group (Fig. 5) . In addition, CYP3A protein levels in the HFϩI group after PB treatment were reduced to 79 Ϯ 1% of those in the HF group. CYP2C11 protein levels in the SD and SDϩI groups were elevated after PB treatment, but the levels in the HF and HFϩI groups were not significantly influenced. In contrast, there was no significant increase in protein levels of CYP2E1, CYP4A, and NADPH-P450 reductase in the four diet groups after PB treatment.
Effect of PB Treatment on Hepatic Expression of mRNAs and Proteins of Transcription Factors in Rats Fed the Four Diets.
CAR and PXR function as a heterodimer with RXR␣, and HNF4␣ functions as a homodimer, regulating genes encoding CYP2B, CYP2C, and CYP3A (Honkakoski et al., 1998; Lehmann et al., 1998; Bogan et al., 2000; Tirona et al., 2003; Chen et al., 2005) . We next analyzed the effects of the SD, SDϩI, HF, and HFϩI diets and PB treatment on the expression of CAR, PXR, RXR␣, and HNF4␣ mRNAs in the liver. There was no significant change in the baseline mRNA levels of CAR, PXR, and RXR␣ in the four diet groups except that the levels of CAR were slightly increased in the HF and HFϩI groups ( Table 2 ). The mRNA levels of CAR and PXR after PB treatment exhibited a trend toward reduced levels in the four diet groups. No significant difference was observed in the mRNA levels of RXR␣ after PB treatment in the four diet groups. The baseline mRNA levels of HNF4␣ in the HF and HFϩI groups and the treated levels in the HF group exhibited a trend toward reduced levels, and PB-treated levels in the HFϩI group were reduced and lower than those in the HF group. 
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We further investigated the effect of the diets and PB treatment on the protein levels of nuclear receptors in the liver nucleus. As shown in Fig. 6 , the protein levels of CAR in the nucleus were increased after PB treatment, but no difference was observed between the levels of the HF and HFϩI groups. No significant difference was found in the baseline and PB-treated protein levels of PXR and RXR␣ in the four diet groups. In contrast, the baseline and PB-treated protein levels of HNF4␣ in the HF group were decreased to 86 Ϯ 5% and 77 Ϯ 7%, respectively, of the ones in the SD group, and the baseline and PB-treated levels in the HFϩI group were 78 Ϯ 13% and 46 Ϯ 5%, respectively, of those in the SDϩI group. In addition, the treated protein levels in the HFϩI group were significantly lower than in the HF group.
Transcriptional cofactor PGC1␣ is considered to regulate biological programs linked to energy homeostasis through specific interaction with a variety of transcription factors such as nuclear hormone receptors (Puigserver and Spiegelman, 2003) . Here, we investigated whether the expression of hepatic PGC1␣ mRNA and protein is influenced by the four diets and PB treatment. As shown in Table 2 , no significant change in the baseline and treated levels of the four diet groups was detected, whereas a trend toward reduced PGC1␣ mRNA levels after PB treatment was observed in the four diet groups. Correspondingly, the baseline and treated levels of PGC1␣ protein were not significantly changed in the liver nucleus of rats fed each of four diets except that PB-treated levels of PGC1␣ protein in the SD group were decreased (Fig. 6 ). These observations indicate that alterations in the PB induction of P450s by feeding the HF and HFϩI diets may not be attributed to reduced levels of PGC1␣ protein in the nucleus of hepatocytes.
Discussion
This study demonstrates that feeding the high-lipid and high-sucrose diet for 8 weeks produces severe hepatic steatosis, which is associated with hepatic injury produced by the administration of xenobiotics such as PB and DEX (Table 1 ; Figs. 1 and 2) . Although large amounts of lipid deposition were evident in the liver sections of the rats, there was no inflammation and fibrosis in the liver of control rats (Fig. 1) . This model is not an experimental model of nonalcoholic steatohepatitis, but is beneficial for investigating the effects of lipid accumulation on xenobiotic-induced liver injury. Liver injury by PB treatment was found in the HF group of 8-week-fed rats but not 4-week-fed rats (Fig. 3) , consistent with the accumulation of hepatic triacylglycerols in the HF group of 8-week-fed rats being markedly higher than that of 4-week-fed rats. As found in liver sections (Fig. 1 ) and serum levels of AST and ALT (Fig. 2) , inulin intake attenuated lipid droplets and PB-and DEX-induced hepatotoxic injury. These results suggest that 1) marked lipid accumulation in hepatocytes may be associated with the induction of liver injury by xenobiotics, and 2) potential preventive effects of dietary inulin on blood glucose and lipid profiles, and hepatic lipid profiles may lead to the prevention of liver injury produced by xenobiotics. Steatosis produced by diets deficient in lipotropes such as choline and methionine (Weltman et al., 1996) and that induced by chemicals such as orotic acid (Su et al., 1999) are established as experimental models of nonalcoholic steatohepatitis and drug-mediated liver injury, respectively. Those models have been reported to be associated with liver injuries via the alteration of hepatic expression of drug-metabolizing enzymes such as CYP2E1, CYP4A, and CYP2C11. In addition, a pathophysiological status such as chemically induced and spontaneous diabetes has been demonstrated to influence the hepatic expression of CYP2B, CYP2C11, CYP3A, and CYP4A (Bellward et al., 1988; Dong et al., 1988; Favreau and Schenkman, 1988; Woodcroft et al., 1999) . Nevertheless, the detailed effects of lipid accumulation on the expression of transcriptional factors, which regulate the gene expression of drugmetabolizing enzymes, remain to be clarified. This study establishes that dietary manipulation such as high lard and high sucrose produces hepatic steatosis associated with xenobiotic-induced liver injury (Figs. 1 and 2; Table 1 ). Thus, in this study, we examined the effects of lipid accumulation on baseline and xenobiotic-treated expression of CYP2E1, CYP2B, CYP2C11, CYP3A, and CYP4A mRNAs and proteins, and the association between alterations in the expression of P450s and transcriptin factors and xenobiotic-induced liver injury. Leclercq et al. (2000) have demonstrated that CYP2E1 in wild-type mice but CYP4A in CYP2e1Ϫ/Ϫ mice is up-regulated in nonalcoholic steatohepatitis and plays a key role in the development of liver injury by initiating lipid peroxidation. In contrast, feeding a high-fat and high-sucrose diet down-regulated CYP2E1 and CYP4A mRNAs and proteins, and even after treatment with PB, the enzymes remained down-regulated (Table 2 ; Fig. 5 ). These results indicate that CYP2E1 and CYP4As seemed not to play a central role in this PB-induced liver injury.
Rats fed the HFϩI diet exhibited reduced induction in response to PB treatment as evidenced by PROD activities and CYP2B mRNA and protein levels (Tables 1 and 2; Fig. 5) . Zannikos et al. (1993) have demonstrated that rats fed the energy-dense diet for 32 weeks as compared with rats fed the control diet exhibit a lower increase in PROD activities after PB treatment (20-fold increase versus 45-fold increase), whereas similar amounts of protein and mRNA of CYP2B1/ 2B2 are found. Hepatic nutritional status in this experimental model appears to be rather different from the energy-dense diet model; lipid accumulation in the liver of rats fed the HF diet for 8 weeks was more than 2-fold higher than that of rats fed the energy-dense diet for 32 weeks. As pointed out by Zannikos et al. (1993) , the change in the microsomal lipid environment based on diet and/or aging may influence enzyme activity.
PB activates CAR and PXR, which bind to and transactivate CYP2B and CYP3A promoters (Honkakoski et al., 1998; Lehmann et al., 1998) . HNF4␣ synergistically enhanced CAR-and PXR-mediated xenobiotic induction of human CYP2C9 (Chen et al., 2005) and CYP3A (Tirona et al., 2003) . Although there is no direct evidence that HNF4␣ synergistically enhances the CAR-and PXR-mediated xenobiotic induction of CYP2B, the CYP2B2 phenobarbital response unit contains an HNF4 binding site (Beaudet et al., 2005) . In addition, single nucleotide polymorphism in a putative HNF4 binding site in the phenobarbital response element of CYP2B6 has been demonstrated to be correlated with lowered CYP2B6 expression . By a study using HNF4 antisense RNA, it has been demonstrated that HNF4 is a general regulator of major drug-metabolizing P450s such as CYP3A4, CYP3A5, CYP2A6, CYP2B6, CYP2C9, and CYP2D6 (Jover et al., 2001) . Thus, in this study, we assessed whether the reduced PB induction of CYP2B and CYP3A mRNAs and proteins in the HFϩI group may be attributable to a decline in the expression of transcription factors. Although PGC1␣ has been demonstrated to mediate the ligand-independent activation of CAR (Shiraki et al., 2003) , the levels of PGC1␣ mRNA and protein in the HFϩI group were similar to those of the control of the SDϩI and HF groups (Table 2; Fig. 6 ), suggesting that PGC1␣ may not play a central role in the preventive action of dietary inulin. There was no significant change FIG. 6 . Effects of phenobarbital treatment on nuclear receptor protein levels in rats fed SD, SDϩI, HF, and HFϩI for 8 weeks. Rats were fed the four diets for 8 weeks and then administered PB (80 mg/kg, i.p.) once daily for 4 days, and then sacrificed. The nuclear proteins (20 g/lane) were prepared and subjected to immunoblot analysis. The signal intensities were determined with a Fujix BAS-2000 bioimage analyzer (Fuji Photo Film). Relative levels are expressed by taking the control values obtained from SD-fed and vehicle-treated animals as 100. ‫,ء‬ p Ͻ 0.05, ‫,ءء‬ p Ͻ 0.01, ‫,ءءء‬ p Ͻ 0.001 for SDϩI-, HF-, or HFϩI-fed and vehicle-administered animals versus SD-fed and vehicle-administered animals or SDϩI-, HF-, or HFϩI-fed and PB-administered animals versus SD-fed and PB-administered animals; ϩ, p Ͻ 0.05, ϩϩϩ, p Ͻ 0.001 for PB-administered animals versus vehicle-administered animals; ##, p Ͻ 0.01 for HFϩI-fed and PB-administered animals versus HF-fed and PB-administered animals.
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at ASPET Journals on October 20, 2017 dmd.aspetjournals.org based on HF and HFϩI diets in the baseline and PB-treated expression of CAR, PXR, and RXR␣ mRNAs and proteins except for increased levels of CAR mRNA in the vehicle-treated HFϩI group (Table 2; Fig. 6 ). In contrast, HNF4␣ protein significantly declined in the liver nucleus of rats fed the HF and HFϩI diets (Fig. 6) . Thus, the reduced induction of hepatic CYP2B and CYP3A in the PB-treated HFϩI group may be attributable to a decline in the expression of HNF4␣ protein in the liver nucleus. Serum glucose levels were increased in HF-fed and vehicle-treated rats, and inulin-supplemented diet suppressed the increase (Table 1) . Furthermore, the levels in HF-fed rats after PB treatment exhibited a tendency to remain increased. Glucose itself has been demonstrated to induce the expression of HNF4␣ mRNA in primary-cultured rat hepatocytes (Oyadomari et al., 2000) . Thus, the lower levels of HNF4␣ mRNA and protein in the PB-treated HFϩI group than those in the HF group may be associated with suppression of increase in serum glucose by inulin. Dhe-Paganon et al. (2002) presume that fatty acids or related molecules might be the endogenous ligands for HNF4␣; that is, HNF4␣ may function as a biosensor for fatty acids within the cell. However, it remains to be addressed whether the decreased expression of HNF4␣ protein is influenced by the liver lipid environment; that is, marked accumulation of liver fatty acids as found in the HF and HFϩI groups. Analysis of the HNF4␣ gene expression is currently progressing in our laboratory.
We proposed the scheme of PB-induced liver injury associated with lipid accumulation and the suppression by inulin. Absorption of a high-fat and high-sucrose diet was concomitant with increases in blood glucose and liver lipids (Table 1) . Glucose has been demonstrated to induce transciption factors such as sterol regulatory element binding protein-1c, which enhances transcription of genes involved in de novo lipogenesis such as fatty acid synthase, leading to increased syntheses of fatty acids and triacylglycerols. Kinoshita et al. (2002) have demonstrated that a significant increase of hydroxy radical levels by day 4 of high-dose treatment with PB accompanied the accumulation of 8-hydroxydeoxyguanosine in the nucleus. In fact, as indicated by the accumulation of TBARS, lipid peroxides were slightly increased in the HF groups after PB treatment (Fig. 4) . It is possible that CYP2B and CYP3A induced by PB exposure may contribute to produce reactive oxygen species or that changed microsomal lipid environment may prevent the elimination of oxygen radicals leading to lipid peroxidation. On the other hand, Zhang et al. (2002) have demonstrated that overdoses of acetaminophen cause significant hepatotoxicity via a pathway mediated by CAR, because PB increases susceptibility to acetaminophen damage in wild-type but not in CAR null mice. Furthermore, because PXR(Ϫ/Ϫ) mice are less sensitive to acetaminophen hepatotoxicity, PXR appears to be an important modulator (Wolf et al., 2005) . In addition, Dai et al. (2005) have presented that RXR␣ regulates the expression of glutathione S-transferase genes and modulates acetaminophen-glutathione conjugation in mouse liver, because RXR␣ null mice are protected from acetaminophen-induced hepatotoxicity and exhibit greater levels of acetaminophen-glutathione in the liver. Thus, a potential hepatotoxic compound in fatty liver may cause acute liver failure after PB treatment via a CAR-and/or PXR-mediated pathway or associated with an RXR␣-glutathione Stransferase regulatory network (Fig. 7) . Together, we speculate that inulin suppresses increase in blood glucose, which leads to a coordinate suppression of lipogenic gene transcription, causing, in turn, a decrease in excessive accumulation of liver lipids, and reduces expression of HNF4␣, causing a decrease in xenobiotic-induced expression of CYP2B and CYP3A. The model may explain the inhibitory effect of inulin on xenobiotic-induced liver failure.
